True Wealth Design’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9K Buy
160
+37
+30% +$13.7K 0.01% 411
2026
Q1
$36K Buy
123
+46
+60% +$15.1K 0.01% 495
2025
Q4
$27K Sell
77
-40
-34% -$13.5K 0.01% 508
2025
Q3
$37.9K Buy
117
+95
+432% +$29.5K 0.01% 397
2025
Q2
$8.65K Sell
22
-1
-4% -$402 ﹤0.01% 629
2025
Q1
$10.1K Buy
23
+17
+283% +$6.82K ﹤0.01% 471
2024
Q4
$2.3K Sell
6
-1
-14% -$418 ﹤0.01% 703
2024
Q3
$3.64K Hold
7
﹤0.01% 643
2024
Q2
$3.79K Hold
7
﹤0.01% 300
2024
Q1
$3.63K Buy
7
+3
+75% +$1.49K ﹤0.01% 298
2023
Q4
$1.89K Hold
4
﹤0.01% 310
2023
Q3
$1.74K Hold
4
﹤0.01% 277
2023
Q2
$1.78K Hold
4
﹤0.01% 281
2023
Q1
$1.84K Hold
4
﹤0.01% 339
2022
Q4
$2.05K Buy
+4
New +$2.03K ﹤0.01% 297

Other funds holding ELV

True Wealth Design's ELV Position: Q2 2026 in Review

True Wealth Design increased its Elevance Health (ELV) stake by 30% in Q2 2026, buying an estimated $13.7K and bringing the position to 160 shares worth $61.9K. The position accounts for 0.01% of the portfolio, ranked #411.

True Wealth Design first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • True Wealth Design held 160 shares of Elevance Health worth $61.9K as of Q2 2026.
  • True Wealth Design bought 37 Elevance Health shares in Q2 2026, an estimated $13.7K.
  • Elevance Health made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #411 holding.
  • True Wealth Design first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.